Rating History for Inhibrx Biosciences (INBX) by SMBC Nikko Securities
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 3/16/2022 | David Dai | New Coverage | Outperform (N/A) |
40.00 (N/A) |
20.19 (69.18) |
242.64% | Details |
